Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: A systematic review and meta-analysis of individual participant data

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 3, 2015, Pages 440-451.e6

  Singh, Siddharth ^a   Venkatesh, Sudhakar K ^a   Wang, Zhen ^a   Miller, Frank H ^b   Motosugi, Utaroh ^c   Low, Russell N ^d   Hassanein, Tarek ^e   Asbach, Patrick ^f   Godfrey, Edmund M ^g   Yin, Meng ^a   Chen, Jun ^a   Keaveny, Andrew P ^h   Bridges, Mellena ^h   Bohte, Anneloes ⁱ   Murad, Mohammad Hassan ^a   Lomas, David J ^g   Talwalkar, Jayant A ^a   Ehman, Richard L ^a  

^a MAYO CLINIC   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d MC 0677   (United States)

^e Southern California Liver Centers   (United States)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g ADDENBROOKE S HOSPITAL   (United Kingdom)

^h MAYO CLINIC   (United States)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Diagnostic performance; Elastography; IPD; Noninvasive; Pooled analysis

Indexed keywords

ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; BODY MASS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; ELASTOGRAPHY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MAGNETIC RESONANCE ELASTOGRAPHY; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PREVALENCE; SENSITIVITY ANALYSIS; ADULT; AGED; BIOPSY; CYTOCHEMISTRY; ECHOGRAPHY; EVALUATION STUDY; FEMALE; LIVER; MALE; MIDDLE AGED; PATHOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOPSY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84925297945     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.09.046     Document Type: Article

References (54)

1. Everhart J.E., Ruhl C.E. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology 2009, 136:1134-1144.
2. Asrani S.K., Larson J.J., Yawn B., et al. Underestimation of liver-related mortality in the United States. Gastroenterology 2013, 145:375-382.
3. Bravo A.A., Sheth S.G., Chopra S. Liver biopsy. NEngl J Med 2001, 344:495-500.
4. Regev A., Berho M., Jeffers L.J., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002, 97:2614-2618.
5. Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012, 142:1293-1302.
6. Venkatesh S.K., Yin M., Ehman R.L. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. JMagn Reson Imaging 2013, 37:544-555.
7. Kim D., Kim W.R., Talwalkar J.A., et al. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology 2013, 268:411-419.
8. Ichikawa S., Motosugi U., Ichikawa T., et al. Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci 2012, 11:291-297.
9. Venkatesh S.K., Wang G., Lim S.G., et al. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol 2014, 24:1-9.
10. Guo Y., Parthasarathy S., Goyal P., et al. Magnetic resonance elastography and acoustic radiation force impulse for staging hepatic fibrosis: a meta-analysis. Abdom Imaging 2014, Epubahead of print. http://dx.doi.org/10.1007/s00261-014-0137-6.
11. Wang Q.B., Zhu H., Liu H.L., et al. Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 2012, 56:239-247.
12. Riley R.D., Lambert P.C., Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 2010, 340:c221.
13. Stewart L.A., Parmar M.K. Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet 1993, 341:418-422.
14. Moher D., Liberati A., Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. W64.
15. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
16. Whiting P., Rutjes A.W., Reitsma J.B., et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
17. Alonzo T.A., Pepe M.S. Distribution-free ROC analysis using binary regression techniques. Biostatistics 2002, 3:421-432.
18. Youden W.J. Index for rating diagnostic tests. Cancer 1950, 3:32-35.
19. Jaeschke R., Guyatt G.H., Sackett D.L. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994, 271:703-707.
20. Altman D.G., Bland J.M. Interaction revisited: the difference between two estimates. BMJ 2003, 326:219.
21. Batheja M.J., Silva A.C., De Petris G., et al. Role of magnetic resonance elastography in assessing hepatic fibrosis. Gastroenterology 2011, 140:S927.
22. Choi Y.R., Lee J.M., Yoon J.H., et al. Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis. Invest Radiol 2013, 48:607-613.
23. Kim B.H., Lee J.M., Lee Y.J., et al. MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. JMagn Reson Imaging 2011, 34:1110-1116.
24. Yoon J.H., Lee J.M., Woo H.S., et al. Staging of hepatic fibrosis: comparison of magnetic resonance elastography and shear wave elastography in the same individuals. Korean J Radiol 2013, 14:202-212.
25. Lee V.S., Miller F.H., Omary R.A., et al. Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients. Transplantation 2011, 92:581-586.
26. Loomba R., Wolfson T., Ang B., et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology 2014, 60:1920-1928.
27. Huwart L., Peeters F., Sinkus R., et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed 2006, 19:173-179.
28. Huwart L., Salameh N., ter Beek L., et al. MR elastography of liver fibrosis: preliminary results comparing spin-echo and echo-planar imaging. Eur Radiol 2008, 18:2535-2541.
29. Huwart L., Sempoux C., Salameh N., et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 2007, 245:458-466.
30. Huwart L., Sempoux C., Vicaut E., et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008, 135:32-40.
31. Bohte A.E., de Niet A., Jansen L., et al. Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C. Eur Radiol 2014, 24:638-648.
32. Rouviere O., Yin M., Dresner M.A., et al. MR elastography of the liver: preliminary results. Radiology 2006, 240:440-448.
33. Crespo S., Bridges M., Nakhleh R., et al. Non-invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C. Clin Transplant 2013, 27:652-658.
34. Klatt D.A.P., Kamphues C., Hirsch S., et al. MR elastography of liver transplant patients using parallel imaging techniques. Proc Intl Soc Mag Reson Med 2011, 19:1485.
35. Asbach P., Klatt D., Hamhaber U., et al. Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med 2008, 60:373-379.
36. Asbach P., Klatt D., Schlosser B., et al. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology 2010, 257:80-86.
37. Chen J., Talwalkar J.A., Yin M., et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 2011, 259:749-756.
38. Godfrey E.M., Patterson A.J., Priest A.N., et al. Acomparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol 2012, 22:2790-2797.
39. Klatt D., Asbach P., Rump J., et al. Invivo determination of hepatic stiffness using steady-state free precession magnetic resonance elastography. Invest Radiol 2006, 41:841-848.
40. Low R.N., Hassanein T. MR elastography: validation and reproducibility of measurements of mean liver stiffness and fibrosis. JHepatol 2012, 56:S415.
41. Nguyen D., Talwalkar J.A., Yin M., et al. Assessment of hepatic fibrosis by magnetic resonance elastography in patients with sclerosing cholangitis. Gastroenterology 2011, 140:S919.
42. Rustogi R., Horowitz J., Harmath C., et al. Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. JMagn Reson Imaging 2012, 35:1356-1364.
43. Wang Y., Ganger D.R., Levitsky J., et al. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 2011, 196:553-561.
44. Yin M., Talwalkar J.A., Glaser K.J., et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007, 5:1207-1213.
45. Friedrich-Rust M., Ong M.F., Martens S., et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008, 134:960-974.
46. Castera L., Foucher J., Bernard P.H., et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010, 51:828-835.
47. Bota S., Sporea I., Sirli R., et al. Factors associated with the impossibility to obtain reliable liver stiffness measurements by means of acoustic radiation force impulse (ARFI) elastography-analysis of a cohort of 1,031 subjects. Eur J Radiol 2014, 83:268-272.
48. Myers R.P., Pomier-Layrargues G., Kirsch R., et al. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. JHepatol 2012, 56:564-570.
49. Petta S., Di Marco V., Camma C., et al. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther 2011, 33:1350-1360.
50. Sagir A., Erhardt A., Schmitt M., et al. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008, 47:592-595.
51. Kim S.U., Kim J.K., Park Y.N., et al. Discordance between liver biopsy and Fibroscan(R) in assessing liver fibrosis in chronic hepatitis B: risk factors and influence of necroinflammation. PLoS One 2012, 7:e32233.
52. Tapper E.B., Cohen E.B., Patel K., et al. Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol 2012, 10:932-937 e1.
53. Ichikawa S., Motosugi U., Nakazawa T., et al. Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography. JMagn Reson Imaging 2014, Epub ahead of print. http://dx.doi.org/10.1002/jmri.24666.
54. Singh S., Fujii L.L., Murad M.H., et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death inpatients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013, 11:1573-1584.